Overview
Research context and commercial specification.
A gut-derived metabolite of ellagitannins, present in pomegranate and other ellagitannin-rich fruits and now produced by controlled multi-step synthesis. Urolithin A is studied less as a free-radical scavenger than as an upstream regulator of mitochondrial quality control — the machinery that tags and clears damaged organelles. The result is a distinct mechanistic profile, a simple and photostable molecule, and one of the most extensively characterised actives on the mitochondrial axis.
Research direction
At a glance
| CAS number | 1143-70-0 |
| INCI name | Urolithin A |
| Molecular formula | C13H8O4 |
| Molecular weight | 228.20 g/mol |
| Purity | ≥99.0% |
| Appearance | Pale yellow to yellow powder |
| Grade | Research grade / Ultra-pure |
| Solubility | Poorly soluble in water; soluble in DMSO and ethanol |
| Storage | Cool, dry, protected from light — 25 °C |
| Shelf life | 36 months unopened |
| Packaging | 25 kg / drum |
| Origin | Synthetic, multi-step controlled synthesis |
| Analytical methods | HPLC (purity, assay) · LC-MS (identity) · Residual solvents (GC) |
| Certification | ISO 9001 · GMP |
Published references
This library is synchronized from PubMed and shows bibliographic metadata only (title, authors, journal, year, link). No abstract or full text is reproduced. Papers flagged as context-dependent are included for scientific completeness and require careful interpretation.
-
Molecules2026Urolithin A: Biosynthesis at a Glance and Biological Properties Supported by Recent Preclinical and Clinical Evidence.Open in PubMed →
-
Mitochondrion2026Urolithin A plus EGCG enhances mitophagy associated pathways, mitochondrial dynamics, and bioenergetic function in humanized amyloid-β knock-in mice.Open in PubMed →
-
Metabolism2026Aflatoxin B1-induced metabolic remodeling promotes liver injury through an H3K18la-ACSL4-ferroptosis axis attenuated by Urolithin A.Open in PubMed →
-
In Vivo2026Urolithin A Attenuates Noise-induced Hearing Loss and Is Associated With Increased Cochlear Mitophagy Markers.Open in PubMed →
Technical questions
What is urolithin A and how is it specified?
Which analytical methods verify this active?
How should urolithin A be handled in formulation?
Ask about this active
Request the complete specification dossier, a sample, or formulation guidance for Creatrich Biotech actives.